Fresenius's Sale of Part of Fresenius Medical Care Stake Is Positive -- Market Talk

Dow Jones

Mar 04, 2025

0935 GMT - Fresenius's sale of a portion of its stake in Fresenius Medical Care is a positive step that gives the former a source of funds to reduce debt and continue its strategy, Jefferies analysts say in a research note. German healthcare company Fresenius's 32.2% stake in Fresenius Medical Care has loomed over both companies, according to Jefferies. Fresenius cut its stake in the dialysis business to just above 25% by selling a 3.6% stake and a 600 million-euro bond exchangeable for an additional 3.5% stake, raising 1.1 billion euros in total. Shares in Fresenius Medical Care drop 7.1% to 44.10 euros, below the 44.50 euro level at which Fresenius sold the stake. Fresenius shares fall 0.6%. (adria.calatayud@wsj.com)

(END) Dow Jones Newswires

March 04, 2025 04:35 ET (09:35 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2516550625"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2516550625\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2516550625?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-04 17:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2516550625","market":"other","top_or_hot":-1,"title":"Fresenius's Sale of Part of Fresenius Medical Care Stake Is Positive -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0935 GMT - Fresenius's sale of a portion of its stake in Fresenius Medical Care is a positive step that gives the former a source of funds to reduce debt and continue its strategy, Jefferies analysts say in a research note. German healthcare company Fresenius's 32.2% stake in Fresenius Medical Care has loomed over both companies, according to Jefferies. Fresenius cut its stake in the dialysis business to just above 25% by selling a 3.6% stake and a 600 million-euro bond exchangeable for an additional 3.5% stake, raising 1.1 billion euros in total. Shares in Fresenius Medical Care drop 7.1% to 44.10 euros, below the 44.50 euro level at which Fresenius sold the stake. Fresenius shares fall 0.6%. (adria.calatayud@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 04, 2025 04:35 ET (09:35 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fresenius's Sale of Part of Fresenius Medical Care Stake Is Positive -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFresenius's Sale of Part of Fresenius Medical Care Stake Is Positive -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-04 17:35</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0935 GMT - Fresenius's sale of a portion of its stake in Fresenius Medical Care is a positive step that gives the former a source of funds to reduce debt and continue its strategy, Jefferies analysts say in a research note. German healthcare company Fresenius's 32.2% stake in Fresenius Medical Care has loomed over both companies, according to Jefferies. Fresenius cut its stake in the dialysis business to just above 25% by selling a 3.6% stake and a 600 million-euro bond exchangeable for an additional 3.5% stake, raising 1.1 billion euros in total. Shares in Fresenius Medical Care drop 7.1% to 44.10 euros, below the 44.50 euro level at which Fresenius sold the stake. Fresenius shares fall 0.6%. (adria.calatayud@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 04, 2025 04:35 ET (09:35 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FSNUY","symbol_name":"Fresenius SE & Co. KGaA","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2516550625","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2516550625","pubTimestamp":1741080900,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0935 GMT - Fresenius's sale of a portion of its stake in Fresenius Medical Care is a positive step that gives the former a source of funds to reduce debt and continue its strategy, Jefferies analysts say in a research note. German healthcare company Fresenius's 32.2% stake in Fresenius Medical Care has loomed over both companies, according to Jefferies. Fresenius cut its stake in the dialysis business to just above 25% by selling a 3.6% stake and a 600 million-euro bond exchangeable for an additional 3.5% stake, raising 1.1 billion euros in total. Shares in Fresenius Medical Care drop 7.1% to 44.10 euros, below the 44.50 euro level at which Fresenius sold the stake. Fresenius shares fall 0.6%. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"FSNUY":"Fresenius SE & Co. KGaA","BK4196":"保健护理服务","FMS":"费森尤斯医疗"},"translate_title":"费森尤斯出售部分费森尤斯医疗股份是积极的——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FSNUY":0.9,"FMS":0.9},"content_text":"0935 GMT - Fresenius's sale of a portion of its stake in Fresenius Medical Care is a positive step that gives the former a source of funds to reduce debt and continue its strategy, Jefferies analysts say in a research note. German healthcare company Fresenius's 32.2% stake in Fresenius Medical Care has loomed over both companies, according to Jefferies. Fresenius cut its stake in the dialysis business to just above 25% by selling a 3.6% stake and a 600 million-euro bond exchangeable for an additional 3.5% stake, raising 1.1 billion euros in total. Shares in Fresenius Medical Care drop 7.1% to 44.10 euros, below the 44.50 euro level at which Fresenius sold the stake. Fresenius shares fall 0.6%. (adria.calatayud@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2025 04:35 ET (09:35 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}